Progyny, Inc. Debt/Equity

Debt/Equity of PGNY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Debt/Equity growth rates and interactive chart. The debt-to-equity (D/E) ratio is calculated by dividing a company's total interest-bearing liabilities by its shareholder equity. These numbers are available on the balance sheet of a company's financial statements. The ratio is used to evaluate a company's financial leverage. The debt/equity ratio can be compared to a company's historical average or to peers. A ratio above 1 indicates the company has more debt than equity and a ratio above 3 is considered high. Below 0.5 means the company has little debt and significant capacity to expand it.


Highlights and Quick Summary

  • Debt/Equity for the quarter ending June 29, 2021 was 0.04 (a -11.88% decrease compared to previous quarter)
  • Year-over-year quarterly Debt/Equity increased by Infinity%
  • Annual Debt/Equity for 2020 was 0.05 (a Infinity% increase from previous year)
  • Annual Debt/Equity for 2019 was 0.0 (a -100.0% decrease from previous year)
  • Annual Debt/Equity for 2018 was -1.12 (a -3.7% decrease from previous year)
Visit stockrow.com/PGNY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Debt/Equity of Progyny, Inc.

Most recent Debt/Equityof PGNY including historical data for past 10 years.

Interactive Chart of Debt/Equity of Progyny, Inc.

Progyny, Inc. Debt/Equity for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 0.04 0.05
2020 0.05 0.0 0.0 0.0 0.05
2019 0.0 0.0 -0.03 0.0 0.0
2018 -0.0 0.0 0.0 -1.12
2017 -0.05 -1.16

Business Profile of Progyny, Inc.

Sector: Healthcare
Industry: Health Information Services
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.